2010Military Medical Journal of Southeast ChinaRequires access

Observation of therapeutic effects of three drugs on paroxysmal atrial fibrillation

Zhang Bi-ch

Open publisher page 0 citations

Abstract

Objective To investigate the efficacy and safety of propafenone,admiodarane,metoprolol and tartrate capsules(Betaloc) in treating and preventing of paroxysmal atrial fibrillation(PAF).Methods 80 patients with atrial fibrillation were randomly divided into propafenone(n=32),admiodarane(n=28) and metoprolol group(n=20).Results The recovery rates within 48 hours after treatment in propafenone,admiodarane and metoprolol group were 72%,75% and 65% respectively.No significant difference was found in three groups(P0.05).There was no significant difference among different age groups(P0.05).The occurrence rates of adverse reactions in the propafenone,admiodarane and metoprolol group were 16%,14% and 15% respectively.There was no significant difference(P0.05).No serious side effect or arrhythmia was found.Conclusion Three drugs are effective and relatively safe in the treatment and prevention of the relapse of PAF.

About this research paper

What this paper is about

Objective To investigate the efficacy and safety of propafenone,admiodarane,metoprolol and tartrate capsules(Betaloc) in treating and preventing of paroxysmal atrial fibrillation(PAF).Methods 80 patients with atrial fibrillation were randomly divided into propafenone(n=32),admiodarane(n=28) and metoprolol group(n=20).Results The recovery rates within 48 hours after treatment in propafenone,admiodarane and metoprolol group were 72%,75% and 65% respectively.No significant difference was found in three groups(P0.05).There was no significant difference among different age groups(P0.05).The occurrence rates of adverse reactions in the propafenone,admiodarane and metoprolol group were 16%,14% and 15% respectively.There was no significant difference(P0.05).No serious side effect or arrhythmia was found.Conclusion Three drugs are effective and relatively safe in the treatment and prevention of the relapse of PAF.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the efficacy and safety of propafenone,admiodarane,metoprolol and tartrate capsules(Betaloc) in treating and preventing of paroxysmal atrial fibrillation(PAF).Methods 80 patients with atrial fibrillation were randomly divided into propafenone(n=32),admiodarane(n=28) and metoprolol group(n=20).Results The recovery rates within 48 hours after treatment in propafenone,admiodarane and metoprolol group were 72%,75% and 65% respectively.No significant difference was found in three groups(P0.05).There was no significant difference among different age groups(P0.05).The occurrence rates of adverse reactions in the propafenone,admiodarane and metoprolol group were 16%,14% and 15% respectively.There was no significant difference(P0.05).No serious side effect or arrhythmia was found.Conclusion Three drugs are effective and relatively safe in the treatment and prevention of the relapse of PAF.

Key concepts: Propafenone, Medicine, Metoprolol, Atrial fibrillation, Metoprolol Tartrate, Paroxysmal atrial fibrillation, Significant difference, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation of therapeutic effects of three drugs on paroxysmal atrial fibrillation — Research Paper | ScholarLens